Keynotes announced for Research and Innovation 2024

Drug discovery innovation

The European Laboratory Research & Innovation Group (ELRIG) UK has announced the keynote speakers for its upcoming Research & Innovation conference: Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma.  

The event, taking place at the University of Manchester from 20–21 March 2024, will focus on accelerating drug discovery. 

This free-to-attend event will bring together scientists, researchers and entrepreneurs to discuss how emerging biology and innovative technologies are pioneering new medicines enabling the next generation of therapeutics.  

It will comprise four main sessions covering animal-free technologies, oncology drug discovery, tackling antimicrobial resistance as well as advances in mass spectrometry techniques and proteomics. There will also be a trade show and exhibition, a poster competition, and networking opportunities. 

TechBio Breakthrough Zone

ELRIG will also be launching the TechBio Breakthrough Zone at Research & Innovation 2024. The new exhibition space provides young companies with the opportunity to present their technology and connect with potential customers and collaborators. There is also an opportunity to nominate early-career professionals for ELRIG’s Impact Award which will recognise an individual for their scientific contribution and its impact on early-stage drug discovery.  

Sarah Brockbank, Conference Director, ELRIG UK and Strategy Leader, Complex Medicines, Medicines Discovery Catapult, said: “We have an outstanding line up of speakers covering key focus areas in drug discovery and development. These world-leading experts will share their insights and experiences on the challenges and opportunities in the field, and we are honoured to have Steve Bates and Dr Anderson Ryan on board as keynote speakers.” 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free